Clinical Trial NCT05972967
Trial
Omeros – OMSS906-PNH-001 (NCT05972967)
Clinical trial ID
NCT05972967
Drug name
OMS906
Company:
Omeros
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
---
Current status
Recruiting
Start
03/2023
Substance
---
Research question
Safety, tolerability, pharmok inetics, pharmacodynamics & effiacy when ravulizumab has failed
Delivery method of drug
i.v.
Frequency
Every eight weeks
Clinical trial locations
Germany Greece Switzerland UK